Deficiency of clusterin exacerbates high-fat diet-induced insulin resistance in male mice

Endocrinology

Volumn 155, Issue 6, 2014, Pages 2089-2101

  Kwon, Min Jung ^a   Ju, Tae Jin ^a   Heo, Jung Yoon ^a   Kim, Yong Woon ^a   Kim, Jong Yeon ^a   Won, Kyu Chang ^a   Kim, Jae Ryong ^a   Bae, Young Kyung ^a   Park, In Sun ^b   Min, Bon Hong ^c   Lee, In Kyu ^d   Park, So Young ^a  

^a Yeungnam University College of Medicine   (South Korea)

^b Inha University School of Medicine   (South Korea)

^c Korea University College of Medicine   (South Korea)

^d Kyungpook National University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; C PEPTIDE; CLUSTERIN; CYTOKINE; GLUCOSE; INSULIN; MESSENGER RNA; PALMITIC ACID; PROTEIN KINASE B; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; FAT MASS; GENE EXPRESSION; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORT; HOMEOSTASIS; INFLAMMATION; INSULIN RESISTANCE; LIPID DIET; LIVER; LIVER CELL; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CARBONYLATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SKELETAL MUSCLE; ANIMAL; C57BL MOUSE; CELL CULTURE; DEFICIENCY; FLOW CYTOMETRY; GENETICS; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BODY WEIGHT; CELLS, CULTURED; CLUSTERIN; DIET, HIGH-FAT; FLOW CYTOMETRY; GLUCOSE TOLERANCE TEST; HEPATOCYTES; INSULIN RESISTANCE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROTEIN CARBONYLATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84901475946     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2013-1870     Document Type: Article

References (48)

1. de Silva HV, Stuart WD, Park YB, et al. Purification and characterization of apolipoprotein J. J Biol Chem. 1990;265: 14292-14297.
2. Aronis KN, Kim YB, Mantzoros CS. Clusterin (apolipoprotein J): wither link with diabetes and cardiometabolic risk? Metabolism. 2011;60: 747-748.
3. Bettuzzi S. Conclusions and perspectives. Adv Cancer Res. 2009; 105: 133-150.
4. Jenne DE, Lowin B, Peitsch MC, Böttcher A, Schmitz G, Tschopp J. Clusterin (complement lysis inhibitor) forms a high density lipoprotein complex with apolipoprotein A-I in human plasma. J Biol Chem. 1991;266: 11030-11036.
5. Trougakos IP, Gonos ES. Clusterin/apolipoprotein J in human aging and cancer. Int J Biochem Cell Biol. 2002;34: 1430-1448.
6. Trougakos IP, Poulakou M, Stathatos M, Chalikia A, Melidonis A, Gonos ES. Serum levels of the senescence biomarker clusterin/apolipoprotein J increase significantly in diabetes type II and during development of coronary heart disease or at myocardial infarction. Exp Gerontol. 2002;37: 1175-1187.
7. Rizzi F, Bettuzzi S. Clusterin (CLU) and prostate cancer. Adv Cancer Res. 2009;105: 1-19.
8. Watari H, Ohta Y, Hassan MK, Xiong Y, Tanaka S, Sakuragi N. Clusterin expression predicts survival of invasive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy. Gynecol Oncol. 2008;108: 527-532.
9. Kujiraoka T, Hattori H, Miwa Y, et al. Serum apolipoprotein j in health, coronary heart disease and type 2 diabetes mellitus. J Atheroscler Thromb. 2006;13: 314-322.
10. Hoofnagle AN, Wu M, Gosmanova AK, et al. Low clusterin levels in high-density lipoprotein associate with insulin resistance, obesity, and dyslipoproteinemia. Arterioscler Thromb Vasc Biol. 2010;30: 2528-2534.
11. DaimonM, Oizumi T, Karasawa S, et al. Association of the clusterin gene polymorphisms with type 2 diabetes mellitus. Metabolism. 2011;60: 815-822.
12. Jung GS, Kim MK, Jung YA, et al. Clusterin attenuates the development of renal fibrosis. J Am Soc Nephrol. 2012;23: 73-85.
13. McLaughlin L, Zhu G, Mistry M, et al. Apolipoprotein J/clusterin limits the severity of murine autoimmune myocarditis. J Clin Invest. 2000;106: 1105-1113.
14. SungHK, SungHK, KimYW, et al. COMP-angiopoietin-1 enhances skeletal muscle blood flow and insulin sensitivity in mice. Am J Physiol Endocrinol Metab. 2009;297: E402-E409.
15. Seo HY, Kim MK, Jung YA, et al. Clusterin decreases hepatic SREBP-1c expression and lipid accumulation. Endocrinology. 2013;154: 1722-1730.
16. Song SE, Kim YW, Kim JY, Lee DH, Kim JR, Park SY. IGFBP5 mediates high glucose-induced cardiac fibroblast activation. J Mol Endocrinol. 2013;50: 291-303.
17. Bae SK, Cha HN, Ju TJ, et al. Deficiency of inducible nitric oxide synthase attenuates immobilization-induced skeletal muscle atrophy in mice. J Appl Physiol. 2012;113: 114-123.
18. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957;226: 497-509.
19. 2stress triggers a release of transforming growth factor-β 1, which induces biomarkers of cellular senescence of human diploid fibroblasts. J Biol Chem. 2001;276: 2531-2537.
20. Calvo EL, Mallo GV, Fiedler F, et al. Clusterin overexpression in rat pancreas during the acute phase of pancreatitis and pancreatic development. Eur J Biochem. 1998;254: 282-289.
21. Viard I, Wehrli P, Jornot L, et al. Clusterin gene expression mediates resistance to apoptotic cell death induced by heat shock and oxidative stress. J Invest Dermatol. 1999;112: 290-296.
22. Hardardóttir I, Kunitake ST, Moser AH, et al. Endotoxin and cytokines increase hepatic messenger RNA levels and serum concentrations of apolipoprotein J (clusterin) in Syrian hamsters. J Clin Invest. 1994;94: 1304-1309.
23. Boden MJ, Brandon AE, Tid-Ang JD, et al. Overexpression of manganese superoxide dismutase ameliorates high-fat diet-induced insulin resistance in rat skeletal muscle. Am J Physiol Endocrinol Metab. 2012;303: E798-E805.
24. Riant E, Waget A, Cogo H, Arnal JF, Burcelin R, Gourdy P. Estrogens protect against high-fat diet-induced insulin resistance and glucose intolerance in mice. Endocrinology. 2009;150: 2109-2117.
25. Jordan-Starck TC, Lund SD, Witte DP, et al. Mouse apolipoprotein J: characterization of a gene implicated in atherosclerosis. J Lipid Res. 1994;35: 194-210.
26. Laping NJ, Olson BA, Day JR, et al. The age-related increase in renal clusterinmRNAis accelerated in obese Zucker rats. JAmSoc Nephrol. 1998;9: 38-45.
27. Monte SV, Caruana JA, Ghanim H, et al. Reduction in endotoxemia, oxidative and inflammatory stress, and insulin resistance after Roux-en-Y gastric bypass surgery in patients with morbid obesity and type 2 diabetes mellitus. Surgery. 2012;151: 587-593.
28. Ghanim H, Monte SV, Sia CL, et al. Reduction in inflammation and the expression of amyloid precursor protein and other proteins related to Alzheimer's disease following gastric bypass surgery. J Clin Endocrinol Metab. 2012;97: E1197-E1201.
29. Savkovi V, Gantzer H, Reiser U, et al. Clusterin is protective in pancreatitis through anti-apoptotic and anti-inflammatory properties. Biochem Biophys Res Commun. 2007;356: 431-437.
30. Dumont P, Chainiaux F, Eliaers F, et al. Overexpression of apolipoprotein J in human fibroblasts protects against cytotoxicity and premature senescence induced by ethanol and tert-butylhydroperoxide. Cell Stress Chaperones. 2002;7: 23-35.
31. Miyake H, Hara I, Gleave ME, Eto H. Protection of androgendependent human prostate cancer cells from oxidative stress-induced DNA damage by overexpression of clusterin and its modulation by androgen. Prostate. 2004;61: 318-323.
32. Lee YN, Shim YJ, Kang BH, Park JJ, Min BH. Over-expression of human clusterin increases stress resistance and extends lifespan in Drosophila melanogaster. Biochem Biophys Res Commun. 2012; 420: 851-856.
33. Van Linthout S, Spillmann F, Riad A, et al. Human apolipoprotein A-I gene transfer reduces the development of experimental diabetic cardiomyopathy. Circulation. 2008;117: 1563-1573.
34. StuartWD, Krol B, Jenkins SH, Harmony JA. Structure and stability of apolipoprotein J-containing high-density lipoproteins. Biochemistry. 1992;31: 8552-8559.
35. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev. 2002;23: 599-622.
36. Yuzefovych L, Wilson G, Rachek L. Different effects of oleate vs. palmitate on mitochondrial function, apoptosis, and insulin signaling in L6 skeletal muscle cells: role of oxidative stress. Am J Physiol Endocrinol Metab. 2010;299: E1096-E1105.
37. Styskal J, Nwagwu FA, Watkins YN, et al. Methionine sulfoxide reductase A affects insulin resistance by protecting insulin receptor function. Free Radic Biol Med. 2013;56: 123-132.
38. Boden G, Sargrad K, Homko C, Mozzoli M, Stein TP. Effect of a low-carbohydrate diet on appetite, blood glucose levels, and insulin resistance in obese patients with type 2 diabetes. Ann Intern Med. 2005;142: 403-411.
39. Ayala JE, Bracy DP, Malabanan C, et al. Hyperinsulinemic-euglycemic clamps in conscious, unrestrained mice. J Vis Exp. 2011; 16.pii: 3188.
40. Ayala JE, Bracy DP, McGuinness OP, Wasserman DH. Considerations in the design of hyperinsulinemic-euglycemic clamps in the conscious mouse. Diabetes. 2006;55: 390-397.
41. Andrikopoulos S, Proietto J. The biochemical basis of increased hepatic glucose production in a mouse model of type 2 (non-insulindependent) diabetes mellitus. Diabetologia. 1995;38: 1389-1396.
42. Sun Y, Liu S, Ferguson S, et al. Phosphoenolpyruvate carboxykinase overexpression selectively attenuates insulin signaling and hepatic insulin sensitivity in transgenic mice. J Biol Chem. 2002;277: 23301-23307.
43. Kim BM, Kim SY, Lee S, et al. Clusterin induces differentiation of pancreatic duct cells into insulin-secreting cells. Diabetologia. 2006; 49: 311-320.
44. Kim BM, Han YM, Shin YJ, Min BH, Park IS. Clusterin expression during regeneration of pancreatic islet cells in streptozotocin-induced diabetic rats. Diabetologia. 2001;44: 2192-2202.
45. Gelissen IC, Hochgrebe T, WilsonMR, et al. Apolipoprotein J (clusterin) induces cholesterol export from macrophage-foam cells: a potential anti-atherogenic function? Biochem J. 1998;331(pt 1): 231-237.
46. Kim JK, Fillmore JJ, Chen Y, et al. Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proc Natl Acad Sci USA. 2001;98: 7522-7527.
47. Turner N, Kowalski GM, Leslie SJ, et al. Distinct patterns of tissuespecific lipid accumulation during the induction of insulin resistance in mice by high-fat feeding. Diabetologia. 2013;56: 1638-1648.
48. Hwang JH, Stein DT, Barzilai N, et al. Increased intrahepatic triglyceride is associated with peripheral insulin resistance: in vivoMR imaging and spectroscopy studies. Am J Physiol Endocrinol Metab. 2007;293: E1663-E1669.